CAS No. 1254053-43-4
Batch:
Purity:99.83
Chemical Structure
Check the
ASP2215 (Gilteritinib)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | 6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide | |
|---|---|---|
| CAS Number | 1254053-43-4 | |
| Molecular Formula |
C29H44N8O3 |
|
| Molecular Weight (MW) | 552.71 | |
| SMILES | CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5 | |
| InChIKey | GYQYAJJFPNQOOW-UHFFFAOYSA-N |
Gilteritinib (ASP2215) is a small-molecule inhibitor of FLT3 and AXL, exhibiting approximately 800-fold higher potency for FLT3 over c-KIT. By selectively blocking receptor tyrosine kinase activity, gilteritinib suppresses downstream STAT5, AKT, and ERK signaling pathways, thereby inhibiting cell proliferation and inducing apoptosis in acute myeloid leukemia models.
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
4 mg/mL
(7.23 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
5 mg/mL
(9.04 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Ethanol | 4 mg/mL |
| Water | Insoluble |
| Ethanol | 11 mg/mL |
| DMSO |
4 mg/mL
(7.23 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Water | Insoluble |
| DMSO |
10 mg/mL
(18.09 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 6 mg/mL |
| Water | ˂1 mg/mL |
| DMSO |
5 mg/mL
(9.04 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.) |
| Ethanol | 5 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- ASP2215 (Gilteritinib) Mechanism of Action: FLT3 Inhibition in Leukemic Blast Cells Research
- ASP2215 (Gilteritinib) Clinical Trials
- ASP2215 (Gilteritinib) Working Concentration | Cell Culture | Treatment
- ASP2215 (Gilteritinib) Solubility in DMSO
- ASP2215 (Gilteritinib) Stock Solution
- ASP2215 (Gilteritinib) Storage
- ASP2215 (Gilteritinib) Stability
- ASP2215 (Gilteritinib) Combination Database
- ASP2215 (Gilteritinib) Molecular Weight
- ASP2215 (Gilteritinib) SMILES
- ASP2215 (Gilteritinib) Chemical Structure (2D and 3D)
- ASP2215 (Gilteritinib) IC50 for Cell-based and Cell-free Assays
- ASP2215 (Gilteritinib) Sigma (AMBH324AB971)? Try a better option.
- ASP2215 (Gilteritinib) MedChemExpress (HY-12432)? Try a better option.
- ASP2215 (Gilteritinib) Cayman (21503)? Try a better option.
- ASP2215 (Gilteritinib) APExBIO (A4691)? Try a better option.
- ASP2215 (Gilteritinib) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.